Latest Production News

Altech Batteries has launched an operational pilot plant in Germany producing its proprietary Silumina Anodes, promising a 50% increase in lithium-ion battery capacity with improved longevity.

Austal Limited has announced a record-breaking $14.2 billion order book, underpinned by strong US and Australian defence contracts, and raised its FY2025 EBIT guidance to at least $80 million.

NZME Limited has received eight director nominations from major shareholders ahead of its June 2025 Annual Shareholders’ Meeting, prompting the Board to propose an alternative composition focused on digital transformation and governance stability.

Turaco Gold Limited has updated its Afema Project mineral resource estimate to 3.55 million ounces of gold, marking a 40% increase since August 2024, while retracting a prior production target due to regulatory compliance concerns.

Foresta Group Holdings’ subsidiary partners with New Zealand’s EECA to explore geothermal steam for its flagship biomass facility, aiming to boost sustainability and efficiency.

Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Kinatico (ASX:KYP) has upgraded its SaaS revenue forecast for the second half of FY25 to $8.3 million, driven by strong demand for its compliance and credential validation software. The company’s recent sales hires and April launch of Kinatico Compliance underpin this optimistic outlook.

Infinity Mining has executed a binding agreement to divest its Leonora Goldfields Project interest to U Resource, which will transfer it to Evergreen Lithium (ASX: EG1). Infinity retains exposure through a substantial EG1 shareholding while refocusing on its core assets.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Felix Gold Limited has successfully raised $17 million through a two-tranche placement, bolstering its cash reserves to advance exploration and development in Alaska’s prolific Fairbanks Gold District.